IBDEI29N ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,38427,1,3,0)
 ;;=3^Inhalant Induced Mild Neurocog Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,38427,1,4,0)
 ;;=4^F18.288
 ;;^UTILITY(U,$J,358.3,38427,2)
 ;;=^5003403
 ;;^UTILITY(U,$J,358.3,38428,0)
 ;;=F18.988^^145^1864^10
 ;;^UTILITY(U,$J,358.3,38428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38428,1,3,0)
 ;;=3^Inhalant Induced Mild Neurocog Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,38428,1,4,0)
 ;;=4^F18.988
 ;;^UTILITY(U,$J,358.3,38428,2)
 ;;=^5003415
 ;;^UTILITY(U,$J,358.3,38429,0)
 ;;=F18.159^^145^1864^11
 ;;^UTILITY(U,$J,358.3,38429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38429,1,3,0)
 ;;=3^Inhalant Induced Psychotic Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,38429,1,4,0)
 ;;=4^F18.159
 ;;^UTILITY(U,$J,358.3,38429,2)
 ;;=^5003387
 ;;^UTILITY(U,$J,358.3,38430,0)
 ;;=F18.259^^145^1864^12
 ;;^UTILITY(U,$J,358.3,38430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38430,1,3,0)
 ;;=3^Inhalant Induced Psychotic Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,38430,1,4,0)
 ;;=4^F18.259
 ;;^UTILITY(U,$J,358.3,38430,2)
 ;;=^5003400
 ;;^UTILITY(U,$J,358.3,38431,0)
 ;;=F18.959^^145^1864^13
 ;;^UTILITY(U,$J,358.3,38431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38431,1,3,0)
 ;;=3^Inhalant Induced Psychotic Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,38431,1,4,0)
 ;;=4^F18.959
 ;;^UTILITY(U,$J,358.3,38431,2)
 ;;=^5003412
 ;;^UTILITY(U,$J,358.3,38432,0)
 ;;=F18.99^^145^1864^20
 ;;^UTILITY(U,$J,358.3,38432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38432,1,3,0)
 ;;=3^Inhalant Related Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,38432,1,4,0)
 ;;=4^F18.99
 ;;^UTILITY(U,$J,358.3,38432,2)
 ;;=^5133360
 ;;^UTILITY(U,$J,358.3,38433,0)
 ;;=F70.^^145^1865^1
 ;;^UTILITY(U,$J,358.3,38433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38433,1,3,0)
 ;;=3^Intellectual Disabilities,Mild
 ;;^UTILITY(U,$J,358.3,38433,1,4,0)
 ;;=4^F70.
 ;;^UTILITY(U,$J,358.3,38433,2)
 ;;=^5003668
 ;;^UTILITY(U,$J,358.3,38434,0)
 ;;=F71.^^145^1865^2
 ;;^UTILITY(U,$J,358.3,38434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38434,1,3,0)
 ;;=3^Intellectual Disabilities,Moderate
 ;;^UTILITY(U,$J,358.3,38434,1,4,0)
 ;;=4^F71.
 ;;^UTILITY(U,$J,358.3,38434,2)
 ;;=^5003669
 ;;^UTILITY(U,$J,358.3,38435,0)
 ;;=F72.^^145^1865^3
 ;;^UTILITY(U,$J,358.3,38435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38435,1,3,0)
 ;;=3^Intellectual Disabilities,Severe
 ;;^UTILITY(U,$J,358.3,38435,1,4,0)
 ;;=4^F72.
 ;;^UTILITY(U,$J,358.3,38435,2)
 ;;=^5003670
 ;;^UTILITY(U,$J,358.3,38436,0)
 ;;=F73.^^145^1865^4
 ;;^UTILITY(U,$J,358.3,38436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38436,1,3,0)
 ;;=3^Intellectual Disabilities,Profound
 ;;^UTILITY(U,$J,358.3,38436,1,4,0)
 ;;=4^F73.
 ;;^UTILITY(U,$J,358.3,38436,2)
 ;;=^5003671
 ;;^UTILITY(U,$J,358.3,38437,0)
 ;;=F78.^^145^1865^5
 ;;^UTILITY(U,$J,358.3,38437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38437,1,3,0)
 ;;=3^Intellectual Disabilities,Oth Specified
 ;;^UTILITY(U,$J,358.3,38437,1,4,0)
 ;;=4^F78.
 ;;^UTILITY(U,$J,358.3,38437,2)
 ;;=^5003672
 ;;^UTILITY(U,$J,358.3,38438,0)
 ;;=F79.^^145^1865^6
 ;;^UTILITY(U,$J,358.3,38438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38438,1,3,0)
 ;;=3^Intellectual Disabilities,Unspec
 ;;^UTILITY(U,$J,358.3,38438,1,4,0)
 ;;=4^F79.
 ;;^UTILITY(U,$J,358.3,38438,2)
 ;;=^5003673
 ;;^UTILITY(U,$J,358.3,38439,0)
 ;;=Z00.6^^145^1866^1
 ;;^UTILITY(U,$J,358.3,38439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38439,1,3,0)
 ;;=3^Exam of Participant of Control in Clinical Research Program
 ;;^UTILITY(U,$J,358.3,38439,1,4,0)
 ;;=4^Z00.6
